(Q34186610)

31 July 2017

1 reference

title

Allogeneic stem cell transplantation for acute lymphocytic leukemia in adults (English)

1 reference

stem cell transplantation

31 July 2017

0 references

1 reference

1 reference

acute lymphocytic leukemia

inferred from title

1 reference

Martin TG

1

1 reference

PubMed ID

11253611

31 July 2017

Gajewski JL

series ordinal

2

1 reference

31 July 2017

1 February 2001

1 reference

Hematology / Oncology Clinics of North America

31 July 2017

1 reference

31 July 2017

15

1 reference

31 July 2017

97-120

1 reference

31 July 2017

1

1 reference

Outcome of treatment in children with Philadelphia chromosome-positive acute lymphoblastic leukemia

31 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970201-X

7 January 2021

Marrow transplantation from related donors other than HLA-identical siblings

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970201-X

7 January 2021

Bone-Marrow Ablation and Allogeneic Marrow Transplantation in Acute Leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970201-X

7 January 2021

Allogeneic bone marrow transplantation for acute lymphoblastic leukemia during first complete remission

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970201-X

7 January 2021

Successful reinduction of patients with acute lymphoblastic leukemia who relapse following bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970201-X

7 January 2021

Role of induction chemotherapy and bone marrow transplantation in adult lymphoblastic lymphoma: a report on 62 patients from a single center

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970201-X

7 January 2021

Allogeneic bone marrow transplantation after hyperfractionated total-body irradiation and cyclophosphamide in children with acute leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970201-X

7 January 2021

Chemotherapy versus transplantation in acute leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970201-X

7 January 2021

Use of nonmyeloablative preparative regimens for allogeneic blood stem cell transplantation: induction of graft-vs.-malignancy as treatment for malignant diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970201-X

7 January 2021

Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970201-X

7 January 2021

Acute lymphoblastic leukemia. A comprehensive review with emphasis on biology and therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970201-X

7 January 2021

Allogeneic bone marrow transplantation for high-risk acute lymphoblastic leukemia in first remission: long-term results for 42 patients conditioned with an intensified regimen (TBI, high-dose Ara-C and melphalan)

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970201-X

7 January 2021

Intensive postremission chemotherapy without maintenance therapy in adults with acute lymphoblastic leukemia. Dutch Hemato-Oncology Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970201-X

7 January 2021

The role of bone marrow transplantation in adult acute lymphocytic leukemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970201-X

7 January 2021

Lessons learned from the development of an abl tyrosine kinase inhibitor for chronic myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970201-X

7 January 2021

Outcome of Philadelphia chromosome-positive adult acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970201-X

7 January 2021

Adoptive chemoimmunotherapy of cancer in animals: a review of results, principles, and problems

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970201-X

7 January 2021

Bone-Marrow Transplantation for Hematologic Neoplasia in 16 Patients with Identical Twins

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970201-X

7 January 2021

Allogeneic bone marrow transplantation as therapy for primary induction failure for patients with acute leukemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970201-X

7 January 2021

Etoposide, cyclophosphamide, total-body irradiation, and allogeneic bone marrow transplantation for hematologic malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970201-X

7 January 2021

Outcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970201-X

7 January 2021

Factors affecting the outcome of allogeneic bone marrow transplantation for adult patients with refractory or relapsed acute leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970201-X

7 January 2021

Faster neutrophil and platelet engraftment, but no differences in acute GVHD or survival, using peripheral blood stem cells from related and unrelated donors, compared to bone marrow

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970201-X

7 January 2021

BONE-MARROW TRANSPLANTATION IN HIGH-RISK ACUTE LYMPHOBLASTIC LEUKAEMIA IN FIRST AND SECOND REMISSION

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970201-X

7 January 2021

Chemotherapy compared with bone marrow transplantation for adults with acute lymphoblastic leukemia in first remission

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970201-X

7 January 2021

Non-Hodgkin's lymphoma protocols in the treatment of patients with Burkitt's lymphoma and lymphoblastic lymphoma: a report on 58 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970201-X

7 January 2021

Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970201-X

7 January 2021

Comparison of autologous and allogeneic bone marrow transplantation for treatment of high-risk refractory acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970201-X

7 January 2021

Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970201-X

7 January 2021

The hyper-CVAD regimen improves outcome in relapsed acute lymphoblastic leukemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970201-X

7 January 2021

Treatment of acute leukemia in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970201-X

7 January 2021

Allogeneic peripheral blood stem cell transplantation for haematological malignancies--an analysis of kinetics of engraftment and GVHD risk

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970201-X

7 January 2021

Prognosis and treatment of lymphoblastic lymphoma in adults: a report on 80 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970201-X

7 January 2021

Relapse of acute leukemia after marrow transplantation: natural history and results of subsequent therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970201-X

7 January 2021

Late relapses after treatment for acute lymphoblastic leukemia in childhood: a population-based study from the Nordic countries

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970201-X

7 January 2021

Chemotherapy vs HLA-identical sibling bone marrow transplants for adults with acute lymphoblastic leukemia in first remission.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970201-X

7 January 2021

Effect of HLA mismatches on the outcome of hematopoietic transplants

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970201-X

7 January 2021

Long-term follow-up of patients who achieved complete remission after donor leukocyte infusions.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970201-X

7 January 2021

Adult acute lymphoblastic leukemia: results of the Iowa HOP-L protocol

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970201-X

7 January 2021

Allogeneic bone marrow transplantation for hematological malignancies--controversies and recent advances

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970201-X

7 January 2021

Outcomes among 562 recipients of placental-blood transplants from unrelated donors

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970201-X

7 January 2021

Very late recurrence of childhood acute lymphoblastic leukemia treated with chemoimmunotherapy: a report of three cases occurring 19, 11, and 9 years after discontinuation of chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970201-X

7 January 2021

Treatment of acute lymphoblastic leukemia in adults: results of the L-10 and L-10M protocols

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970201-X

7 January 2021

Allogeneic bone marrow transplantation vs filgrastim-mobilised peripheral blood progenitor cell transplantation in patients with early leukaemia: first results of a randomised multicentre trial of the European Group for Blood and Marrow Transplantat

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970201-X

7 January 2021

Allogeneic bone marrow transplantation in adult acute lymphoblastic leukemia in first complete remission: a comparative study. French Group of Therapy of Adult Acute Lymphoblastic Leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970201-X

7 January 2021

Long-term follow-up of 23 patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with allogeneic bone marrow transplant in first complete remission.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970201-X

7 January 2021

High-dose therapy and autologous bone marrow transplantation for adult patients with lymphoblastic lymphoma: results of the European Group for Bone Marrow Transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970201-X

7 January 2021

Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970201-X

7 January 2021

Therapy of refractory adult acute lymphoblastic leukemia with vincristine and prednisone plus tandem methotrexate and L-asparaginase. Results of a Cancer and Leukemia Group B Study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970201-X

7 January 2021

Allogeneic bone marrow transplantation in adults with acute lymphoblastic leukemia in first complete remission

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970201-X

7 January 2021

Antileukemic Effect of Graft-versus-Host Disease in Human Recipients of Allogeneic-Marrow Grafts

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970201-X

7 January 2021

Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970201-X

7 January 2021

Allogeneic bone marrow transplantation for acute lymphoblastic leukaemia: risk factors and clinical outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970201-X

7 January 2021

Impact of reinduction regimens for relapsed and refractory acute lymphoblastic leukemia in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970201-X

7 January 2021

Allogeneic bone marrow transplantation for patients with high-risk acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970201-X

7 January 2021

Long-term follow-up of adults with acute lymphoblastic leukemia in first remission treated with chemotherapy or bone marrow transplantation. The Acute Lymphoblastic Leukemia Working Committee

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970201-X

7 January 2021

Adult lymphoblastic lymphoma: clinical features and prognostic factors in 53 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970201-X

7 January 2021

10.1016/S0889-8588(05)70201-X

Identifiers

DOI

1 reference

31 July 2017

1 reference

PubMed ID

11253611